STAGLIANO NANCY purchased 1K shares of PANDION THERAPEUTICS, INC. on the open market
Open‑market purchase worth $18.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/21/2020ACC: 0000899243-20-019863
Director
Since Jul 2020
-42.84K
Net shares
Net seller
$18.0K
Total acquired
1
Open market trades
1B · 0S
6
Total transactions
33.67K acquired · 76.52K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+15K
Price / share
—
Trade value
—
% of position
25.8%
7/21/2020
58.06K→73.07K
Common Stock
Direct
Shares
+1K
Price / share
$18.00
Trade value
$18K
% of position
New position
7/21/2020
0.00→1K
Total
Net shares
+16K
Net value
$18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/21/2020 | C · Conversion | +15K | — | — | 25.8% | 58.06K | 73.07K |
| Common Stock Direct | 7/21/2020 | P · Purchase | +1K | $18.00 | $18K | New position | 0.00 | 1K |
| Total | +16K | $18K | ||||||
Derivative Transactions4
Stock Option (right to buy)
Direct
Converts to
Common Stock
3.67K shares
Shares
+3.67K
Strike price
18.00
Held after
3.67K
Exercisable
—
7/17/2020
Stock Option (right to buy)
Direct
Converts to
Common Stock
14K shares
Shares
+14K
Strike price
18.00
Held after
14K
Exercisable
—
7/17/2020
Series A Preferred Stock
Indirect
Converts to
Common Stock
5.61K shares
Shares
−28.62K
Strike price
Held after
0.00
Exercisable
—
7/21/2020
Series B Preferred Stock
Indirect
Converts to
Common Stock
9.39K shares
Shares
−47.90K
Strike price
Held after
0.00
Exercisable
—
7/21/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock3.67K shares | 7/17/2020 | A · Award | +3.67K | 18.00 | — | 3.67K |
| Stock Option (right to buy) Direct | Common Stock14K shares | 7/17/2020 | A · Award | +14K | 18.00 | — | 14K |
| Series A Preferred Stock Indirect | Common Stock5.61K shares | 7/21/2020 | C · Conversion | −28.62K | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock9.39K shares | 7/21/2020 | C · Conversion | −47.90K | — | 0.00 |